CS206294B1 - Method of isolation of the albumine from the waste fraction of the humen fraction - Google Patents
Method of isolation of the albumine from the waste fraction of the humen fraction Download PDFInfo
- Publication number
- CS206294B1 CS206294B1 CS516979A CS516979A CS206294B1 CS 206294 B1 CS206294 B1 CS 206294B1 CS 516979 A CS516979 A CS 516979A CS 516979 A CS516979 A CS 516979A CS 206294 B1 CS206294 B1 CS 206294B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- albumin
- ethanol
- proteins
- fraction
- paste
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 15
- 239000002699 waste material Substances 0.000 title claims description 12
- 238000002955 isolation Methods 0.000 title claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 59
- 102000009027 Albumins Human genes 0.000 claims description 34
- 108010088751 Albumins Proteins 0.000 claims description 34
- 102000004169 proteins and genes Human genes 0.000 claims description 32
- 108090000623 proteins and genes Proteins 0.000 claims description 32
- 239000006228 supernatant Substances 0.000 claims description 11
- DZTHIGRZJZPRDV-UHFFFAOYSA-N N-acetyltryptophan Chemical compound C1=CC=C2C(CC(NC(=O)C)C(O)=O)=CNC2=C1 DZTHIGRZJZPRDV-UHFFFAOYSA-N 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000002574 poison Substances 0.000 claims description 6
- 231100000614 poison Toxicity 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229960005480 sodium caprylate Drugs 0.000 claims description 5
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 230000009286 beneficial effect Effects 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000012869 ethanol precipitation Methods 0.000 claims description 2
- 238000011156 evaluation Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 230000036512 infertility Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- -1 sodium carboxylate Chemical class 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 102000002572 Alpha-Globulins Human genes 0.000 claims 1
- 108010068307 Alpha-Globulins Proteins 0.000 claims 1
- 102000006395 Globulins Human genes 0.000 claims 1
- 108010044091 Globulins Proteins 0.000 claims 1
- 102000003886 Glycoproteins Human genes 0.000 claims 1
- 108090000288 Glycoproteins Proteins 0.000 claims 1
- 102000015779 HDL Lipoproteins Human genes 0.000 claims 1
- 108010010234 HDL Lipoproteins Proteins 0.000 claims 1
- 102000004895 Lipoproteins Human genes 0.000 claims 1
- 108090001030 Lipoproteins Proteins 0.000 claims 1
- 102000001621 Mucoproteins Human genes 0.000 claims 1
- 108010093825 Mucoproteins Proteins 0.000 claims 1
- 239000013065 commercial product Substances 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 238000005192 partition Methods 0.000 claims 1
- 235000020097 white wine Nutrition 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Description
Vynález sa týká spósobu izolácie albuminu z odpadnej frakcie ludskej plazmy, ktorý sa v roztoku stabilizuje a ostatně bielkoviny sa tepelne denaturujú a potom precipitujú etanolom.The invention relates to a process for the isolation of albumin from the human plasma waste fraction, which is stabilized in solution and, moreover, the proteins are thermally denatured and then precipitated with ethanol.
Podlá literárnych údajov najznámejšie izolačně postupy albuminu z ludskej plazmy sú: Etanolová frakcionácia [E. J. Cohn, L. E. Strong, W. L. Hughes, D. J. Mulford, J. Ashworth, M. Melin, H. L. Taylor: J. Amer. Chem. Soc., 68, 459, (1946)] a jej modifikácia (Nitschmann H., Kistler P., Lergie W.: Helv. Chim. Acta, 37, 866, [1954]).According to literature, the best known isolation procedures for human plasma albumin are: Ethanol fractionation [E. J. Cohn, L. E. Strong, W. L. Hughes, D. J. Mulford, J. Ashworth, M. Melin, H. L. Taylor: J. Amer. Chem. Soc., 68, 459, (1946)] and modifications thereof (Nitschmann, H., Kistler, P., Lergie, W., Helv. Chim. Acta, 37, 866, [1954]).
Rivanolová metoda· [Rejnek J., Bednářik T., Mašek J.: Cs. farm., 10, 407, (1961)].Rivanol method · [Rejnek J., Bednářik T., Mašek J .: Cs. farm., 10, 407 (1961)].
Izolácia pomocou iontomeničov [Rybák M., Rejnek J.: Cs. farm., 7, 80, (1958)].Ion-exchange isolation [Rybák M., Rejnek J .: Cs. farm., 7, 80, (1958)].
Izolácia etylenglykolom [Curling J. M., Borglóf J., Lindouist L. O., Briksson S.: Vox sang., 33, 97, (1977), Vilioen M.: Vox sang., 35, 268, (1978) (Garcia L. A., Ordotnez G. A.: Pat. USA No 4025500)].Ethylene glycol isolation [Curling JM, Borglof J., Lindouist LO, Briksson S .: Vox sang., 33, 97, (1977), Vilioen M .: Vox sang., 35, 268, (1978) (Garcia LA, Ordotnez GA : U.S. Pat. No. 4025500)].
Tepelno-etanolová metoda [Hoch H., Chanutin A.: Arch. of biochem. and biophysic, 51, 27, (1954), Lundblad J. I.: Vox sang., 5, 122, (1960), Gabr Y., Soliman H. R.: Acta biolog, et med. ger., 27, 341, (1971), Schneider W., Lefewre H., Friedler H., Mc Carty L. I.: Blut, 30j 121) (1875), Schneider W,, Wolter D., Mc Carty L. J.: Folia haematol., 104, 116, (1977)].Thermal-ethanol method [Hoch H., Chanutin A .: Arch. of biochem. and biophysic, 51, 27, (1954), Lundblad J.I .: Vox sang., 5, 122, (1960), Gabr Y., Soliman H. R., Acta biolog, et med. ger., 27, 341, (1971), Schneider W., Lefewre H., Friedler H., Mc Carty LI: Blut, 30j 121) (1875), Schneider W. ,, Wolter D., Mc Carty LJ: Folia haematol 104, 116 (1977)].
Pri izolácii albuminu etanolovou frakcionáciou krvnej plazmy vzniká bielkovinový odpad vo formě frakcie IV. Táto sa izoluje pri pH 5,8, iónovej sile 0,1, 40 objemových % etanolu a teplote —6 °C. Uvedená frakcia obsahuje niekolko druhov plazmatických bielkovín, včítane albuminu, kvantitativné získanie ktorého bežne používanými metodami sa nedaří realizovať.Isolation of albumin by ethanol fractionation of blood plasma produces protein waste in the form of Fraction IV. This was isolated at pH 5.8, an ionic strength of 0.1, 40 vol% ethanol and a temperature of - 6 ° C. Said fraction contains several kinds of plasma proteins, including albumin, a quantitative recovery of which the commonly used methods cannot be realized.
Jedným z možných spósobov kvantitativného získania albuminu z odpadnej frakcie IV je modifikácia tepelno-etanolovej metody, ktorá povodně ako východzí materiál využívá l’udskú plazmu, v ktorej zastúpenie jednotlivých bielkovín je podstatné iné ako v odpadnej frakcií IV. Nevýhodou týchto metod je, že sa pracuje pri nízkom percente bielkovín východzieho materiálu, čo zvyšuje nároky na pracovně objemy, nízkej koncentrácii stabilizátora (0,004 M Na kaprylát) a vysokom percente etanolu, čo pri hraničných teplotách (70 °C) móže dochádzať k inreverzibilným změnám v molekule albuminu. Podstatným problémom pri tepelno-etanolovej metóde přípravy albuminu je separácia denaturovaných balastných bielkovín, ktorá sa spravidla prevádza na špeciálnych filtroch, alebo sa vyzráža polyetylénglykolom.One possible way of quantitatively recovering albumin from waste fraction IV is to modify the heat-ethanol method, which uses floods as the starting material for human plasma, in which the proportion of individual proteins is substantially different than in waste fraction IV. The disadvantage of these methods is that they work at a low percentage of protein of the starting material, increasing the demands on working volumes, a low stabilizer concentration (0.004 M per caprylate) and a high percentage of ethanol, which can cause inversible changes at 70 ° C. in an albumin molecule. A major problem in the heat-ethanol method of preparing albumin is the separation of denatured ballast proteins, which is usually converted to special filters or precipitated by polyethylene glycol.
Originálnost navrhovanej izolácie albuminu z odpadnej frakcie IV je v tom, že pri de206294 náturách balastných bielkovín sa používá optimálna koncentrácia kombinovaných stabilizátorov za přítomnosti nízkého· percenta etanolu a vysokého percenta bielkovín, čo má priaznivý vplyv na kvalitu výrobku a výrobnú kapacitu.The originality of the proposed albumin isolation from waste fraction IV is that the de206294 ballast protein coatings use the optimum concentration of the combined stabilizers in the presence of low percent ethanol and high percent protein, which has a beneficial effect on product quality and production capacity.
Jeden z najnáročnějších technologických stupňov, a to izolácia denaturovaných bielkovín sa prevádza účinným, jednoduchým a zatial’ pri tomto spósobe izolácie albuminu neopísaným postupom, precipitáciou etanolom.One of the most demanding technological steps, namely the isolation of denatured proteins, is carried out by an efficient, simple and yet in this method of albumin isolation by an unwritten procedure, ethanol precipitation.
Podstata izolácie albuminu z odpadnej frakcie IV spočívá v tom, že albumin přítomný vo frakcii IV sa v roztoku stabilizuje kaprylátom sodným a acetyl-DL-tryptofanom za podmienok 4—5 obj. % etanolu, pH 6,5— 6,7 a 4,5—5,5 hmot. % bielkovín sa ostatně bielkoviny tepelne denaturujú pri teplote 68 až 69 °C po dobu 30 až 40 minút. Denaturované bielkoviny sa potom precipitujú etanolom za podmienok 12 obj. % etanolu, pHThe essence of isolating albumin from waste fraction IV is that the albumin present in fraction IV is stabilized in solution with sodium caprylate and acetyl-DL-tryptophan under conditions of 4-5 vol. % ethanol, pH 6.5-6.7 and 4.5-5.5 wt. In addition, the protein is thermally denatured at 68 to 69 ° C for 30 to 40 minutes. The denatured proteins are then precipitated with ethanol under conditions of 12 vol. % ethanol, pH
5,1 až 5,3, iónovej sile 0,09 a separujú centrifugáciou. Supernatant obsahujúci albumin sa lyofilizuje, resp. albumin zo supernatantu sa vyzráža etanolom, popřípadě koncentruje iným vhodným spósobom.5.1 to 5.3, an ionic strength of 0.09 and separated by centrifugation. The albumin-containing supernatant is lyophilized, respectively. the albumin from the supernatant is precipitated with ethanol, optionally concentrated by another suitable method.
Příklad prevedeniaExecution example
1000 g pasty frakcie IV sa suspenduje v 5000 ml apyrogénnej vody. K roztoku sa přidá 19 g kaprylátu sodného a 21 g acetylDL-tryptofanu a pri pH 6,5—6,7 a teplote 68 —69 °C sa roztok zohrieva po dobu 30—40 minút. Denaturované bielkoviny sa vyprecipitujú přidáním 650 ml 96 % etanolu pri pH1000 g of Fraction IV paste is suspended in 5000 ml of pyrogen-free water. 19 g of sodium caprylate and 21 g of acetyl DL-tryptophan are added to the solution and the solution is heated for 30-40 minutes at pH 6.5-6.7 and 68-69 ° C. Denatured proteins are precipitated by adding 650 ml of 96% ethanol at pH
5,1—5,3, iónovej sile 0,09, teplote —2°C po dobu 12 hodin. Vyprecipitované bielkoviny sa separujú na vysokootáčkových prietokových centrifugách rýchlosťou 25 1/hod. pri teplote —3 °C a supernatant, obsahujúci albumin sa číri cez azbestocelulózové vložky, filtrát sa rozplňuje do NTS fliaš, rotačně namrazuje pri —45 °C a lyofilizuje za nízkého vákua na špeciálnych sušiacich aparátoch KS 30, alebo LZ45.5.1-5.3, an ionic strength of 0.09, a temperature of -2 ° C for 12 hours. The precipitated proteins are separated on high speed flow centrifuges at a rate of 25 L / h. at -3 ° C and the albumin-containing supernatant is cleared through asbestos cellulose pads, the filtrate is filled into NTS bottles, rotary frozen at -45 ° C and lyophilized under low vacuum on special KS 30 or LZ45 drying apparatuses.
1000 g pasty frakcie IV sa suspenduje v 5000 ml apyrogénnej vody. K roztoku sa přidá 19 g kapry látu sodného a 21 g acetylDL-tryptofanu a pri pH 6,5—6,7 a teplote 68—69 °C sa roztok zohrieva po dobu 30—40 minút. Denaturované bielkoviny sa vyprecipitujú přidáním 650 ml 96 % etanolu pri pH1000 g of Fraction IV paste is suspended in 5000 ml of pyrogen-free water. To the solution were added 19 g of sodium carboxylate and 21 g of acetyl DL-tryptophan, and the solution was heated for 30-40 minutes at pH 6.5-6.7 and 68-69 ° C. Denatured proteins are precipitated by adding 650 ml of 96% ethanol at pH
5,1—5,3, iónovej sile 0,09, teplote —2 °C po dobu 12 hodin. Vyprecipitované bielkoviny sa separujú na vysokootáčkových prietokových centrifugách rýchlosťou 25 1/hod. pri teplote —3 °C a albumin obsiahnutý v supernatante sa vyzráža etanolom za podmienok pH 4,80, iónovej sile 0,1, 40 obj. % etanolu a teplote —8 °C.5.1-5.3, an ionic strength of 0.09, a temperature of -2 ° C for 12 hours. The precipitated proteins are separated on high speed flow centrifuges at a rate of 25 L / h. at -3 ° C and the albumin contained in the supernatant is precipitated with ethanol under conditions of pH 4.80, an ionic strength of 0.1, 40 vol. % ethanol and a temperature of -8 ° C.
1000 g pasty frakcie IV sa suspenduje v 5000 ml apyrogénnej vody. K roztoku sa přidá 19 g kaprylátu sodného a 21 g acetylDL-tryptofanu a pri pH 6,5—6,7 a teplote 68 —69 °C sa roztok zohrieva po dobu 30—40 minút. Denaturované bielkoviny sa vyprecipitujú přidáním 650 ml 96 % etanolu pri pH1000 g of Fraction IV paste is suspended in 5000 ml of pyrogen-free water. 19 g of sodium caprylate and 21 g of acetyl DL-tryptophan are added to the solution and the solution is heated for 30-40 minutes at pH 6.5-6.7 and 68-69 ° C. Denatured proteins are precipitated by adding 650 ml of 96% ethanol at pH
5,1—5,3, iónovej sile 0,09, teplote —2 °C po dobu 12 hodin. Vyprecipitované bielkoviny sa separujú na vysokootáčkových prietokových centrifugách rýchlosťoiu 25 1/hod. pri teplote —3 °C a albumin přítomný v supernatante sa koncentruje na špeciálnom zariadení typu Centriterm, alebo DC 30.5.1-5.3, an ionic strength of 0.09, a temperature of -2 ° C for 12 hours. The precipitated proteins are separated on high speed flow centrifuges at 25 L / h. at - 3 ° C and the albumin present in the supernatant is concentrated on a special Centriterm or DC 30 device.
Výťažnosťyield
Výťažnosť albuminu sa pohybuje od 120 do 140 g lyofilizovaného produktu na 1 kg pasty odpadnej frakcie IV. Dosahovaná výťažnosť je závislá na obsahu albuminu v odpadnej frakcii.The recovery of albumin ranges from 120 to 140 g of lyophilized product per 1 kg of waste fraction IV. The yield obtained is dependent on the albumin content of the waste fraction.
Analytické hodnotenieAnalytical evaluation
V následuj úcej tabufke sú uvedené analytické hodnoty zistené u komerčného přípravku a přípravku vyrobeného podl’a vynálezu a tieto porovnané s požadovanými kritériami normy na albumin.The following table shows the analytical values found for the commercial preparation and the preparation made according to the invention and compared with the required criteria of the albumin standard.
Uvedené výsledky ukazujú, že kvalitativně kritériá přípravku vyrobeného podl’a vynálezu sa nelíšia od komerčného přípravku a vyhovujú normě na albumin.The results shown show that the qualitative criteria of the preparation produced according to the invention do not differ from the commercial preparation and comply with the albumin standard.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS516979A CS206294B1 (en) | 1979-07-25 | 1979-07-25 | Method of isolation of the albumine from the waste fraction of the humen fraction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS516979A CS206294B1 (en) | 1979-07-25 | 1979-07-25 | Method of isolation of the albumine from the waste fraction of the humen fraction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS206294B1 true CS206294B1 (en) | 1981-06-30 |
Family
ID=5396067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS516979A CS206294B1 (en) | 1979-07-25 | 1979-07-25 | Method of isolation of the albumine from the waste fraction of the humen fraction |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS206294B1 (en) |
-
1979
- 1979-07-25 CS CS516979A patent/CS206294B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69019074T2 (en) | Process for the fractionation of plasma proteins. | |
| DE69513751T2 (en) | Purification of alpha-l-proteinase inhibitor using new chromatographic separation conditions | |
| US6835379B2 (en) | Method of producing IgG | |
| US4228154A (en) | Purification of plasma albumin by ion exchange chromatography | |
| US20080242844A1 (en) | Ultra-high Yield Intravenous Immune Globulin Preparation | |
| CN106459140B (en) | Method for purifying immunoglobulins | |
| HU182554B (en) | Process for producing preparation of serum protein for intravenous application | |
| US4670544A (en) | Process for the manufacture of the cold insoluble globulin and pharmaceutical preparation containing it | |
| EP0127603B1 (en) | Process for the preparation of a composition containing a factor viii(ahf) | |
| US4348315A (en) | Process in purification and concentration of the factor VIII-complex | |
| US4476109A (en) | Method of preparing gamma globulin suitable for intravenous administration | |
| DE69329371T2 (en) | Process for the purification of factor VIII-von willebrand factor (FVIII: C-FVW) complex from human plasma | |
| JPH0381290A (en) | Method for producing purified albumin solution | |
| US2958628A (en) | Heat treatable plasma protein product and method of preparation | |
| US3904751A (en) | Process for isolating a fibrin stabilizing factor from human placenta | |
| US7879332B2 (en) | Ultra-high yield intravenous immune globulin preparation | |
| DE60121196T2 (en) | PROCESS FOR MONOMERIZING HUMAN SERUM ALBUMIN POLYMERS | |
| CS206294B1 (en) | Method of isolation of the albumine from the waste fraction of the humen fraction | |
| JPS59231097A (en) | Manufacture of homogeneous human immunological interferon subtype 26k and 21k | |
| DE1189674B (en) | Method for the isolation of alpha-antitrypsin | |
| US3475402A (en) | Process of extracting proteins from mistle press juice by carrier-free electrophoresis | |
| CH629819A5 (en) | Process for the isolation of albumin from human blood plasma | |
| AT391482B (en) | METHOD FOR THE INDUSTRIAL PRODUCTION OF HIGH PURITY HUMAN LEUCOCYTE INTERFERON | |
| DK159164B (en) | METHOD FOR PREPARING HUMAN LEUKOCYTY INTERFERON IN CRYSTALLINE FORM | |
| SU467536A1 (en) | The method of obtaining serum albumin |